Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAABRON PRESS
2020-05-01
|
| Series: | Clinical Hematology International |
| Online Access: | https://www.atlantis-press.com/article/125940362/view |
| _version_ | 1797230240658882560 |
|---|---|
| author | Mohamad Mohty Florent Malard Ali Bazarbachi |
| author_facet | Mohamad Mohty Florent Malard Ali Bazarbachi |
| author_sort | Mohamad Mohty |
| collection | DOAJ |
| first_indexed | 2024-04-24T15:25:21Z |
| format | Article |
| id | doaj.art-315247fde64041e0ad27e3d512654d2d |
| institution | Directory Open Access Journal |
| issn | 2590-0048 |
| language | English |
| last_indexed | 2024-04-24T15:25:21Z |
| publishDate | 2020-05-01 |
| publisher | SAABRON PRESS |
| record_format | Article |
| series | Clinical Hematology International |
| spelling | doaj.art-315247fde64041e0ad27e3d512654d2d2024-04-02T06:24:08ZengSAABRON PRESSClinical Hematology International2590-00482020-05-012210.2991/chi.d.200507.001Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the BetterMohamad MohtyFlorent MalardAli Bazarbachihttps://www.atlantis-press.com/article/125940362/view |
| spellingShingle | Mohamad Mohty Florent Malard Ali Bazarbachi Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better Clinical Hematology International |
| title | Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better |
| title_full | Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better |
| title_fullStr | Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better |
| title_full_unstemmed | Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better |
| title_short | Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better |
| title_sort | bortezomib lenalidomide and dexamethasone as induction therapy prior to autologous transplantation in multiple myeloma the more is likely the better |
| url | https://www.atlantis-press.com/article/125940362/view |
| work_keys_str_mv | AT mohamadmohty bortezomiblenalidomideanddexamethasoneasinductiontherapypriortoautologoustransplantationinmultiplemyelomathemoreislikelythebetter AT florentmalard bortezomiblenalidomideanddexamethasoneasinductiontherapypriortoautologoustransplantationinmultiplemyelomathemoreislikelythebetter AT alibazarbachi bortezomiblenalidomideanddexamethasoneasinductiontherapypriortoautologoustransplantationinmultiplemyelomathemoreislikelythebetter |